Day: May 22, 2025

Unicycive Therapeutics to Present at Upcoming Investor Conferences

Written by Customer Service on May 22, 2025. Posted in Public Companies.

LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at two upcoming virtual investment conferences. Event: Lytham Partners Spring 2025 Investor Conference Type: Fireside ChatDate/Time: Thursday, May 29, 2025, at 12:30 p.m. ET Event: Noble Capital Markets 2025 Emerging Growth Virtual Equity ConferenceType: Corporate Presentation with Moderated Q&ADate/Time: Wednesday, June 4, 2025, at 1 p.m. ET A link to the live and archived webcasts may be accessed on the Unicycive website under the Investors section: Events and Presentations. About Unicycive Therapeutics Unicycive Therapeutics is a biotechnology...

Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Written by Customer Service on May 22, 2025. Posted in Earnings Releases And Operating Results.

• BLA priority review of RP1 plus nivolumab in advanced melanoma proceeding on schedule; manufacturing inspections and late cycle review meeting complete • Full commercial infrastructure for launch in place ahead of July 22nd PDUFA date • Conference call today at 8:00 AM ET WOBURN, Mass., May 22, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth quarter and year ended March 31, 2025 and provided a business update. “As we near our PDUFA date, our commercial organization is now fully hired and ready to execute our first launch in advanced melanoma,” said Sushil Patel, Ph.D., CEO of Replimune. “We have a deep understanding of the market landscape, prescriber adoption...

NexGold Receives Cabinet Approval for the Crown Land Lease at the Goldboro Gold Project

Written by Customer Service on May 22, 2025. Posted in Public Companies.

TORONTO, May 22, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Crown Land Lease and License for the Goldboro Gold Project (“Goldboro” or the “Project”) has been approved by Cabinet and is being granted by the Government of Nova Scotia. The Crown Land Lease and License is an integral step towards the development of the Project and will allow for the potential for infrastructure development on the lands for which it covers, and gives the Company the ability to build and operate an open pit mine, with the associated processing, tailings management and other associate infrastructure (waste rock storage, overburden storage, etc). The lease covers an area of 779 hectares and the License covers an additional 97 hectares of Crown land. Kevin Bullock,...

Aurora Spine Corporation Announces Record First Quarter Financial Results

Written by Customer Service on May 22, 2025. Posted in Public Companies.

– Company to host conference call Today, Thursday, May 22nd at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 22, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2025. All figures are in U.S. dollars. Financial and Business HighlightsFDA Clearance for AERO™ – the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Company’s newest product, the AERO™ Facet Fusion System.Record Q1 revenue – The company reported a record level of revenues for its first quarter. Q1 2025 sales of $4,417,027...

The Joint Corp. Announces Christopher M. Grandpre Elected as Director

Written by Customer Service on May 22, 2025. Posted in Public Companies.

– Franchise and investment banking expert strengthens the board – SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network dedicated to revolutionizing access to chiropractic care and building a leading wellness franchise with a strong business model, announced Christopher M. Grandpre has been elected as a director to help enable the company in achieving its goals of long-term growth in net new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA. Lead Director Matthew E. Rubel stated, “Chris is a stellar board member and franchise expert. As Chairman of Empower Brands, he has worked with the executive team to continue building and growing the leading commercial and residential...

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

Written by Customer Service on May 22, 2025. Posted in Public Companies.

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future POMPANO BEACH, Fla., May 22, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that Jason Matuszewski, CEO of BioStem is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur Of The Year 2025 Florida Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program honors entrepreneurs whose innovations shape the future and pave the way for a thriving...

Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule

Written by Customer Service on May 22, 2025. Posted in Public Companies.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq’s Capital Market’s minimum bid price requirement of $1.00 per share and the minimum stockholders’ equity requirement of $2.5 million. The notice from Nasdaq indicates that the Company is in compliance with the Nasdaq Capital Market’s listing requirements and the Company’s common stock will continue to be listed and traded on Nasdaq. Robert Hayes, CEO of Sharps Technology, commented: “Maintaining our listing on Nasdaq is of critical...

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

Written by Customer Service on May 22, 2025. Posted in Public Companies.

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare the safety and efficacy of two dose levels of Purified Cortrophin Gel for the treatment of acute gout flares PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the initiation of a Phase 4 clinical trial at Massachusetts General Hospital to compare the safety and efficacy of two dose levels (40 USP units and 80 USP units) of Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) for the treatment of acute gout flares. Cortrophin Gel is indicated for short-term administration as an adjunctive therapy during an acute episode or exacerbation...

CSW Industrials Reports Record Fiscal 2025 Fourth Quarter and Record Full Year Results

Written by Customer Service on May 22, 2025. Posted in Earnings Releases And Operating Results.

DALLAS, May 22, 2025 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI or the “Company”) today reported record results for the fiscal 2025 fourth quarter period ended March 31, 2025. Fiscal 2025 Fourth Quarter Highlights (comparisons to fiscal 2024 fourth quarter)Total revenue increased 9.3% to a fourth quarter record of $230.5 million, driven by inorganic growth of 6.3% from the recent acquisitions of Dust Free, PSP Products, and PF WaterWorks, and organic growth of 3.0% Contractor Solutions delivered organic revenue growth of 8.0% in the fourth quarter Net income attributable to CSWI of $35.1 million, or $37.7 million adjusted, increased 18.7% to a fourth quarter record, compared to $31.8 million Earnings per diluted share (“EPS”) of $2.08, or $2.24 adjusted, increased 9.8% to a fourth quarter record,...

KANZHUN LIMITED Announces First Quarter 2025 Financial Results

Written by Customer Service on May 22, 2025. Posted in Earnings Releases And Operating Results.

BEIJING, May 22, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter ended March 31, 2025. First Quarter 2025 HighlightsTotal paid enterprise customers1 in the twelve months ended March 31, 2025 were 6.4 million, an increase of 12.3% from 5.7 million in the twelve months ended March 31, 2024. Average monthly active users2 for the first quarter of 2025 were 57.6 million, an increase of 23.6% from 46.6 million for the same quarter of 2024. Revenues for the first quarter of 2025 were RMB1,923.3 million (US$265.0 million), an increase of 12.9% from RMB1,703.8 million for the same quarter of 2024. Income from operations for the first quarter of 2025 was RMB439.8 million (US$60.6...

Day: May 22, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals